Skip to main content

Table 1 Characteristics of participants (n (%) and mean ± SD

From: Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation

 

Completed (n = 107)

On treatment (n = 55)

Discontinued (n = 45)

Female

53 (50%)

32 (58%)

20 (44%)

Age (years)

41 ± 11

37 ± 12

35 ± 9

Other allergies

77 (73%)

38 (72%)

30 (68%)

Asthma

47 (44%)

28 (53%)

20 (44%)

Year treatment starteda

 2016

20 (39%)

9 (23%)

 2015

18 (35%)

5 (13%)

 2014

8 (8%)

13 (25%)

6 (15%)

 2013

29 (30%)

 

4 (10%)

 2012

14 (14%)

 

7 (18%)

 2011

12 (12%)

 

3 (8%)

 2010

7 (7%)

 

2 (5%)

 2009

12 (12%)

 

1 (3%)

 2008

8 (8%)

 

0

 2007

 2006

7 (7%)

 

2 (5%)

  1. aInformation missing for 20 patients